Drug
IV Vancomycin
IV Vancomycin is a pharmaceutical drug with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_3
2
50%
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 32 (50.0%)
N/A1 (25.0%)
Trials by Status
completed250%
terminated125%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)
NCT01252719
completedphase_3
Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
NCT01252732
unknownnot_applicable
Study of Obese Patients Comparing Two Vancomycin Loading Dose Regimens
NCT02764359
terminatedphase_1
Dose Escalation Trial of Intrasite Vancomycin Pharmacokinetics
NCT01764750
Clinical Trials (4)
Showing 4 of 4 trials
NCT01252719Phase 3
Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)
NCT01252732Phase 3
Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
NCT02764359Not Applicable
Study of Obese Patients Comparing Two Vancomycin Loading Dose Regimens
NCT01764750Phase 1
Dose Escalation Trial of Intrasite Vancomycin Pharmacokinetics
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4